Daphni announced it is co-leading the 20M EUR Series A round. Other co-lead investors were not named in the provided content. Scientific Advisory Board member Dr. Frank Petersen is mentioned, but not as a founder or investor.
About Generare
A Paris-based biotechnology company that generates and characterises novel molecular data from microbial genomes to support drug discovery and expand the chemical space available for developing new medicines.
Paris, France
Read Company ProfileFrequently Asked Questions
What type of funding round did Generare raise?
Generare raised a series-a round.
How much did Generare raise in its series-a?
Generare raised $20,000,000 EUR in its series-a.
Who invested in Generare's series-a?
The investors in Generare's series-a are: Daphni, Alven.
How will Generare use the funds from its series-a?
Generare plans to use the funds for: scale the proprietary high-throughput platform, generate novel molecular datasets, advance drug discovery research and development.